Comparison of NSAIDs activity in COX-2 expressing and non-expressing 2D and 3D pancreatic cancer cell cultures.

about

Comparison of NSAIDs activity in COX-2 expressing and non-expressing 2D and 3D pancreatic cancer cell cultures.

Item

http://www.wikidata.org/entity/Q55379173

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Comparison of NSAIDs activity ...... ncreatic cancer cell cultures.

@en

Comparison of NSAIDs activity ...... ncreatic cancer cell cultures.

@nl

type

Item

label

Comparison of NSAIDs activity ...... ncreatic cancer cell cultures.

@en

Comparison of NSAIDs activity ...... ncreatic cancer cell cultures.

@nl

prefLabel

Comparison of NSAIDs activity ...... ncreatic cancer cell cultures.

@en

Comparison of NSAIDs activity ...... ncreatic cancer cell cultures.

@nl

P1476

Comparison of NSAIDs activity ...... ancreatic cancer cell cultures

@en

P2093

Miglė Paškevičiūtė

http://www.w3.org/2001/XMLSchema#string

Ugnė Čeponytė

http://www.w3.org/2001/XMLSchema#string

P2860

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies

Application of concave microwells to pancreatic tumor spheroids enabling anticancer drug evaluation in a clinically relevant drug resistance model

Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system

Cancer statistics, 2016

Pancreatic cancer

Generation of Homogenous Three-Dimensional Pancreatic Cancer Cell Spheroids Using an Improved Hanging Drop Technique

Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial.

Anti-Inflammatory Agents for Cancer Therapy.

P304

1543-1551

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CMAR.S163747

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vilma Petrikaitė

P577

2018-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29942156

http://www.w3.org/2001/XMLSchema#string

P932

6007190

http://www.w3.org/2001/XMLSchema#string